18:42 Wed 18 Sep 2019
Futura Medical PLC - Director/PDMR Shareholding
Directors' / PDMR Dealing and Grant of Options
Director |
Number |
Exercise |
Exercise period |
Total number |
Total number |
|
|
|
|
|
|
J H Barder |
250,000 |
31p |
|
1,750,000 |
1,085,972 |
|
|
|
|
|
|
A Hildreth |
200,000 |
31p |
|
400,000 |
142,857 |
|
|
|
|
|
|
K W James |
200,000 |
31p |
|
800,000 |
299,581 |
Of the total 1,400,000 options, 1,281,935 were granted under the
The main vesting condition of the options is that the Director/PDMR/employee remains employed with the Company as at the date of exercise. Further disclosures are contained in the tables below.
ENDS
For further information please contact:
Email: Investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
Nominated Adviser and Broker:
Liberum
Bidhi Bhoma/
Tel: +44 (0) 203 100 2000
For media enquiries please contact:
Mary Clark/
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 950 9144
Notes to editors
About
The first European Phase 3 study for MED2005, referred to as "FM57", is a 1,000 patient, dose-ranging, multi-centre, randomised, double blind, placebo-controlled, home use, parallel group study of MED2005 0.2%, 0.4% and 0.6% Glyceryl Trinitrate for the treatment of erectile dysfunction with a 450 patient open label extension. FM57 is progressing on track, with headline data expected by the end of 2019.
Futura is based in
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
|
|
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Chief Executive Officer |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
|
|
||||
b) |
LEI |
21380053QLT46UNV2303 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of
GB0033278473 |
||||
b) |
Nature of the transaction |
Grant of options over Ordinary Shares
|
||||
c) |
Price(s) and volume(s)
|
|
||||
d) |
Aggregated information - Aggregated volume - Price |
N/A single transaction |
||||
e) |
Date of the transaction |
|
||||
f) |
Place of the transaction |
Outside a trading venue |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
|
|
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Finance Director and |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
|
|
||||
b) |
LEI |
21380053QLT46UNV2303 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of
GB0033278473 |
||||
b) |
Nature of the transaction |
Grant of options over Ordinary Shares |
||||
c) |
Price(s) and volume(s)
|
|
||||
d) |
Aggregated information - Aggregated volume - Price |
N/A single transaction |
||||
e) |
Date of the transaction |
|
||||
f) |
Place of the transaction |
Outside a trading venue |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
a) |
|
|
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Executive Director |
||||
b) |
Initial notification/Amendment |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
|
|
||||
b) |
LEI |
21380053QLT46UNV2303 |
||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a) |
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of
GB0033278473 |
||||
b) |
Nature of the transaction |
Grant of options over Ordinary Shares |
||||
c) |
Price(s) and volume(s)
|
|
||||
d) |
Aggregated information - Aggregated volume - Price |
N/A single transaction |
||||
e) |
Date of the transaction |
|
||||
f) |
Place of the transaction |
Outside a trading venue |
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE